Science Explorer Back to mapMap
Discussion

Coherus BioSciences (United States)

Research works
79
▲ 120% vs 2018-21
Citations
1.1k
13.4 per fractional work
Top-10% rate
13.9%
all institutions 10.0%
Open access
52%
world 40%
International
18%
world 18%

Not ranked overall: Coherus BioSciences (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Coherus BioSciences (United States) work in?

In 2022-now, 55% of research at Coherus BioSciences (United States) is in Health Sciences, 38% in Life Sciences. Its largest fields are Medicine (54%), Biochemistry, Genetics and Molecular Biology (22%), Immunology and Microbiology (15%). It does 2.2× the world's share of Life Sciences.

Health Sciences: 24 fractional works · 55.2% of its workMedicine: 23 fractional works · 53.9% of its workOncology: 13 fractional works · 30.4% of its workRadiology, Nuclear Medicine and Imaging: 2 fractional works · 4.7% of its workPulmonary and Respiratory Medicine: 2 fractional works · 3.7% of its workPathology and Forensic Medicine: 1 fractional works · 2.2% of its workSurgery: 1 fractional works · 1.8% of its workEpidemiology: 1 fractional works · 1.4% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 1.3% of its workPhysiology: 1 fractional works · 1.2% of its workHematology: 0 fractional works · 1.1% of its workDermatology: 0 fractional works · 1.0% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.8% of its workPsychiatry and Mental health: 0 fractional works · 0.8% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.8% of its workInfectious Diseases: 0 fractional works · 0.5% of its workReproductive Medicine: 0 fractional works · 0.4% of its workImmunology and Allergy: 0 fractional works · 0.3% of its workHepatology: 0 fractional works · 0.3% of its workNeurology: 0 fractional works · 0.3% of its workGenetics: 0 fractional works · 0.2% of its workOtorhinolaryngology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.6% of its workNursing: 0 fractional works · 0.7% of its workNutrition and Dietetics: 0 fractional works · 0.7% of its workHealth Professions: 0 fractional works · 0.6% of its workGeneral Health Professions: 0 fractional works · 0.4% of its workPharmacy: 0 fractional works · 0.3% of its workLife Sciences: 16 fractional works · 37.9% of its workBiochemistry, Genetics and Molecular Biology: 10 fractional works · 22.3% of its workMolecular Biology: 6 fractional works · 13.5% of its workCancer Research: 2 fractional works · 3.9% of its workGenetics: 1 fractional works · 2.2% of its workClinical Biochemistry: 0 fractional works · 0.8% of its workPhysiology: 0 fractional works · 0.7% of its workBiotechnology: 0 fractional works · 0.3% of its workCell Biology: 0 fractional works · 0.3% of its workBiochemistry: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.3% of its workImmunology and Microbiology: 6 fractional works · 14.8% of its workImmunology: 6 fractional works · 14.1% of its workMicrobiology: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.2% of its workNeuroscience: 0 fractional works · 0.5% of its workNeurology: 0 fractional works · 0.3% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.3% of its workAgricultural and Biological Sciences: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.1% of its workPhysical Sciences: 2 fractional works · 3.5% of its workEngineering: 0 fractional works · 1.0% of its workBiomedical Engineering: 0 fractional works · 1.0% of its workMaterials Science: 0 fractional works · 1.0% of its workMaterials Chemistry: 0 fractional works · 0.5% of its workBiomaterials: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.0% of its workChemistry: 0 fractional works · 0.8% of its workSpectroscopy: 0 fractional works · 0.8% of its workChemical Engineering: 0 fractional works · 0.2% of its workComputer Science: 0 fractional works · 0.2% of its workComputational Theory and Mathematics: 0 fractional works · 0.2% of its workMathematics: 0 fractional works · 0.2% of its workEnvironmental Science: 0 fractional works · 0.1% of its workSocial Sciences: 2 fractional works · 3.5% of its workEconomics, Econometrics and Finance: 1 fractional works · 3.2% of its workEconomics and Econometrics: 1 fractional works · 3.2% of its workSocial Sciences: 0 fractional works · 0.3% of its workLaw: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workALL ITS WORKCoherusBioSciences…44fractional works, 2022-now
Life Sciences38%Physical Sciences3%Health Sciences55%Social Sciences3%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 17 fields, with their numbers
    1. Medicine2353.9%
    2. Nursing00.7%
    3. Health Professions00.6%
    1. Biochemistry, Genetics and Molecular Biology1022.3%
    2. Immunology and Microbiology614.8%
    3. Neuroscience00.5%
    4. Agricultural and Biological Sciences00.2%
    5. Pharmacology, Toxicology and Pharmaceutics00.1%
    1. Engineering01.0%
    2. Materials Science01.0%
    3. Chemistry00.8%
    4. Chemical Engineering00.2%
    5. Computer Science00.2%
    6. Mathematics00.2%
    7. Environmental Science00.1%
    1. Economics, Econometrics and Finance13.2%
    2. Social Sciences00.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.03× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.18× its world share, 10 worksBiochemistry, Geneti…Immunology and Microbiology: 14.67× its world share, 6 worksImmunology and Micro…Neuroscience: 0.33× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.33× its world share, 0 worksPharmacology, Toxico…Chemical Engineering: 0.68× its world share, 0 worksChemical EngineeringChemistry: 0.49× its world share, 0 worksChemistryComputer Science: 0.03× its world share, 0 worksComputer ScienceEngineering: 0.07× its world share, 0 worksEngineeringEnvironmental Science: 0.02× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.28× its world share, 0 worksMaterials ScienceMathematics: 0.13× its world share, 0 worksMathematicsHealth Professions: 0.24× its world share, 0 worksHealth ProfessionsMedicine: 2.80× its world share, 23 worksMedicineNursing: 1.35× its world share, 0 worksNursingEconomics, Econometrics and Finance: 1.48× its world share, 1 worksEconomics, Econometr…Social Sciences: 0.02× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 14.7×. Every wedge is a field page.

All 17 fields, with their numbers
  1. Immunology and Microbiology14.67×6 works
  2. Biochemistry, Genetics and Molecular Biology4.18×10 works
  3. Medicine2.80×23 works
  4. Economics, Econometrics and Finance1.48×1 works
  5. Nursing1.35×0 works
  6. Chemical Engineering0.68×0 works
  7. Chemistry0.49×0 works
  8. Neuroscience0.33×0 works
  9. Pharmacology, Toxicology and Pharmaceutics0.33×0 works
  10. Materials Science0.28×0 works
  11. Health Professions0.24×0 works
  12. Mathematics0.13×0 works
  13. Engineering0.07×0 works
  14. Agricultural and Biological Sciences0.03×0 works
  15. Computer Science0.03×0 works
  16. Environmental Science0.02×0 works
  17. Social Sciences0.02×0 works

Who are the top researchers at Coherus BioSciences (United States)?

Ranked on the quality score, Martin Oft, Daniel J. Chin and Scott McCauley lead among researchers whose main affiliation is Coherus BioSciences (United States).

  1. 1 Martin Oft United States · #223,880 worldwide 7.1k citations · 123 works
  2. 2 Daniel J. Chin United States · #287,385 worldwide 6k citations · 74 works
  3. 3 Scott McCauley United States · #655,739 worldwide 2k citations · 31 works
  4. 4 Varun N. Kapoor United States · #690,470 worldwide 937 citations · 34 works
  5. 5 Barbara K. Finck United States · #802,907 worldwide 4.8k citations · 18 works
  6. 6 Navneet P. Ratti United States · #1,010,856 worldwide 1.3k citations · 34 works
  7. 7 Peter Van Vlasselaer United States · #1,062,113 worldwide 2.9k citations · 64 works
  8. 8 Scott L. Klakamp United States · #1,126,585 worldwide 1.5k citations · 53 works
All ranked researchers at Coherus BioSciences (United States)

What are the most cited papers from Coherus BioSciences (United States)?

The most cited paper from Coherus BioSciences (United States) is "Broad targeting of resistance to apoptosis in cancer" (Ramzi M. Mohammad et al., 2015), with 869 citations. Next come "Cancer prevention and therapy through the modulation of the tumor microenvironment" (393) and "IL-10: Master Switch from Tumor-Promoting Inflammation to Antitumor Immunity" (320).

Most cited papers
#PaperReleasedCitations
1 Broad targeting of resistance to apoptosis in cancer Ramzi M. Mohammad et al. · Seminars in Cancer Biology Open access 28 Apr 2015 869
2 Cancer prevention and therapy through the modulation of the tumor microenvironment Stephanie C. Casey et al. · Seminars in Cancer Biology Open access 11 Apr 2015 393
3 IL-10: Master Switch from Tumor-Promoting Inflammation to Antitumor Immunity Martin Oft · Cancer Immunology Research Mar 2014 320
4 Designing a broad-spectrum integrative approach for cancer prevention and treatment Keith I. Block et al. · Seminars in Cancer Biology Open access180 authors 18 Nov 2015 302
5 PEGylated IL-10 (Pegilodecakin) Induces Systemic Immune Activation, CD8+ T Cell Invigoration and Polyclonal T Cell Expansion in Cancer Patients Aung Naing et al. · Cancer Cell Open access Nov 2018 256
All 59 most cited papers, with filters and sorting

Which keywords describe research at Coherus BioSciences (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Tumor Microenvironment, Cancer, Chemotherapy, Monoclonal Antibodies, Immune Checkpoint Blockade, PD-1 and PD-L1, Immunotherapy and Cancer Therapy.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Tumor Microenvironment6▲ 33×7 topics
  2. Cancer5▲ 8.7×14 topics
  3. Chemotherapy5▲ 15×9 topics
  4. Monoclonal Antibodies4▲ 112×3 topics
  5. Immune Checkpoint Blockade4▲ 80×1 topic
  6. PD-1 and PD-L14▲ 80×1 topic
  7. Inflammation3▲ 3.6×14 topics
  8. Immunotherapy3▲ 10×8 topics
  9. Cancer Immunotherapy3▲ 44×3 topics
  10. Cancer Therapy3▲ 12×6 topics
  11. Immunity3▲ 16×3 topics
  12. Biopharmaceuticals3▲ 117×3 topics
  13. Immunogenicity2▲ 136×2 topics
  14. Therapeutic Antibodies2▲ 80×2 topics
  15. Clinical Trials2▲ 7.5×7 topics
  16. Bioanalytical Methods2▲ 226×1 topic
  17. Biosimilars2▲ 226×1 topic
  18. Hematological Malignancies2▲ 133×2 topics
  19. Antibody Engineering2▲ 78×1 topic
  20. Fc Receptors2▲ 78×1 topic
  21. Glycosylation2▲ 40×2 topics
  22. Antimicrobial Agents2▲ 244×1 topic
  23. Febrile Neutropenia2▲ 244×1 topic
  24. Targeted Therapy2▲ 18×5 topics
  25. Angiogenesis2▲ 11×7 topics
  26. Metabolism2▲ 7.2×4 topics
  27. Antigen Presentation2▲ 37×2 topics
  28. Innate Immunity2▲ 11×2 topics
  29. Activation1▲ 50×1 topic
  30. Dendritic Cells1▲ 37×1 topic
  31. Macrophage1▲ 41×1 topic
  32. Tumor Antigen1▲ 54×1 topic
  33. Apoptosis1▲ 9.7×5 topics
  34. CAR T Cells1▲ 40×1 topic
  35. Chimeric Antigen Receptor1▲ 40×1 topic
  36. Leukemia1▲ 36×2 topics
  37. Lymphoma1▲ 19×2 topics
  38. Tumor Regression1▲ 27×2 topics
  39. Cetuximab1▲ 33×2 topics
  40. Molecular Subtypes1▲ 29×2 topics

Which research topics does Coherus BioSciences (United States) publish most on?

By volume in 2022-now: Cancer Immunotherapy and Biomarkers, Biosimilars and Bioanalytical Methods, Monoclonal and Polyclonal Antibodies Research and Neutropenia and Cancer Infections.

  1. 1 Cancer Immunotherapy and Biomarkers Oncology 4 works
  2. 2 Biosimilars and Bioanalytical Methods Immunology 2 works
  3. 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
  4. 4 Neutropenia and Cancer Infections Oncology 2 works
  5. 5 Immunotherapy and Immune Responses Immunology 1 works
  6. 6 Immune cells in cancer Immunology 1 works
  7. 7 CAR-T cell therapy research Oncology 1 works
  8. 8 Colorectal Cancer Treatments and Studies Oncology 1 works
  9. 9 Cancer-related Molecular Pathways Oncology 1 works
  10. 10 Blood disorders and treatments Genetics 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available51.5%not open48.5%

World: 40% of research is openly available.

with international co-authors18.0%domestic only82.0%

World: 18% is written across borders.

How has Coherus BioSciences (United States)'s research output changed?

Output in 2022-2025 was 120% higher than in 2018-2021.

still counting2010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Coherus BioSciences (United States) as a percentage of every work published that year, 0.00020% in 2024.

still counting0.00010%0.00020%Coherus BioSciences (United States)0.00018% in 202520102020

Fractional works of Coherus BioSciences (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Redwood City

All research institutions in Redwood City

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Coherus BioSciences (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.